Annexon Inc. is a clinical-stage biopharmaceutical company that focuses on developing therapies for patients with autoimmune and neurodegenerative disorders. Its proprietary platform aims to modulate the classical complement pathway to restore balance and re-establish immune homeostasis.
Notification